Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Aurora Innovation, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
19.6
0
82
68
0
0
3
Cost of revenue
0
0
17
Gross profit
0
0
-14
Research and development
107
179
697
677
716
676
745
Selling, general and administrative
25.6
39
116
129
119
110
142
Operating expenses
133
218
813
1,920
835
786
Operating income
-114
-218
-731
-1,852
-835
-786
-901
Other non-operating income
4
-9
15
59
62
56
Pre-tax income
-102
-214
-760
-1,723
-796
-748
-816
Income tax
-7.77
0
-5
0
0
0
0
Net income
-94.1
-214
-755
-1,723
-796
-748
-816
EBITDA
-112
-215
-715
-1,830
-814
-765
-871
EPS, basic
-0.37
-0.79
-1.22
-1.51
-0.60
-0.46
-0.44
EPS, diluted
-0.37
-0.79
-1.22
-1.51
-0.60
-0.46
-0.44
Shares, basic (weighted)
254
271
621
1,143
1,327
1,618
1,839
Shares, diluted (weighted)
254
271
621
1,143
1,327
1,618
1,839
Balance sheet
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
246
387
1,610
262
501
211
221
Short-term investments
0
839
Other current assets
18.9
67
17
17
31
41
Total current assets
406
1,677
1,118
1,217
1,254
1,317
Property, plant and equipment
10.9
94
91
94
104
103
Lease right-of-use assets
90.9
151
138
122
120
85
Goodwill
30
1,114
0
0
0
Intangible assets
52.7
617
618
617
617
617
Other non-current assets
15.6
37
36
37
43
38
Total assets
619
3,690
2,001
2,235
2,138
2,343
Accounts payable
6.5
7.9
Accrued liabilities
3.41
16.1
52
96
89
100
Total current liabilities
32
91
83
111
105
111
Lease liabilities
97.2
135
123
107
105
73
Other non-current liabilities
0.03
4
7
8
5
4
Total liabilities
132
348
217
250
263
203
Paid-in capital
59.2
4,433
4,600
5,594
6,232
7,312
Retained earnings
-0.02
-1,091
-2,814
-3,610
-4,358
-5,174
Other comprehensive income
-336
0
-2
1
1
2
Shareholders' equity
-83
-277
3,342
1,784
1,985
1,875
2,140
Total equity
-83
-277
3,342
1,784
1,985
1,875
2,140
Total liabilities and equity
619
3,690
2,001
2,235
2,138
2,343
Shares outstanding
1,123
1,166
1,529
1,733
1,943
Cash flow statement
FY2019
FY2021
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-94.1
-214
-755
-1,723
-796
-748
-816
Depreciation and amortization
1.84
3
16
22
21
21
30
Stock-based compensation
28.1
17
220
156
160
144
188
Deferred income tax
-7.78
0
-5
0
0
0
0
Change in receivables
3.32
0
0
Change in payables
-0.85
2.19
0.44
Cash from operations
-94.7
-192
-564
-508
-598
-611
-581
Capital expenditures
-3.83
-7
-48
-15
-15
-34
-31
Acquisitions
-23.1
0
294
0
0
Purchases of investments
-746
-120
0
-1,610
-1,297
-1,030
-1,452
Sales and maturities of investments
773
1,320
892
1,238
Cash from investing
-373
343
250
-852
8
-172
-245
Stock issued
0.32
3
8
13
840
497
916
Share buybacks
-755
Cash from financing
635
2
1,540
11
831
492
834
Net change in cash
167
153
1,226
-1,349
241
-291
8
Free cash flow
-98.6
-199
-612
-523
-613
-645
-612
Income taxes paid
0
0.01
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $6.04 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-400.0%
Gross profit / revenue.
Operating margin
-19,400.0%
Operating income / revenue.
EBITDA margin
-18,780.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-18,000.0%
Pre-tax income / revenue.
Net margin
-18,000.0%
Net income / revenue.
FCF margin
-15,020.0%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-13,580.0%
Cash from operations / revenue.
Return on equity (ROE)
-46.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-41.5%
Net income / average total assets.
Return on invested capital (ROIC)
-42.2%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
15,580.0%
Research and development expense / revenue.
SG&A / revenue
3,420.0%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
4,100.0%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1,440.0%
Capital expenditures / revenue.
D&A / revenue
620.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue CAGR, 3y
-64.7%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y
14.1%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
6.3%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
9.6%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
5.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
30.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
13.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
17.2%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
46.7%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
11.4x
Current assets / current liabilities.
Quick ratio
1.24x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.24x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$0.00
Revenue / diluted weighted shares.
FCF per share
-$0.38
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.34
Cash from operations / diluted weighted shares.
Book value per share
$0.98
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
2,421x
Market cap / revenue.
P/B
6.20x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
9.06x
Market cap / tangible book value, when positive.
EV/Sales
2,394x
Enterprise value / revenue.
FCF yield
-6.2%
Free cash flow / market cap.
Earnings yield
-7.4%
Net income / market cap (the inverse of P/E).
What was Aurora Innovation, Inc.'s revenue in fiscal 2025?
Aurora Innovation, Inc. reported revenue of $3.0M for fiscal 2025.
Was Aurora Innovation, Inc. profitable in fiscal 2025?
No. It reported a net loss of $816.0M.
How much free cash flow did Aurora Innovation, Inc. generate in fiscal 2025?
Cash from operations of $581.0M minus capital expenditures of $31.0M left free cash flow of -$612.0M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.